HAMP and chronic kidney disease: In the pathophysiological contexts of chronic inflammation [e.g. cancer, chronic kidney disease (CKD), obesity or autoimmunity], raised hepcidin limits systemic iron availability, contributing to widespread anaemia of inflammation [32–38].